Fu,SwitzerlandAnnuari commerciali , directory aziendali

AFib before and after TAVR linked to significant risks
This included the patients who already had preexisting AFib and the 4 5% of patients who developed new-onset AFib after undergoing TAVR After a median follow-up period of more than three years, the authors found all-cause mortality and all-cause hospitalizations were both more likely among patients with post-TAVR AFib
Management of atrial fibrillation after transcatheter aortic . . .
Atrial Fibrillation (AF) is very common among patients with severe aortic stenosis Moreover, new onset AF (NOAF) is a frequent finding after Transcatheter Aortic Valve Replacement (TAVR) There is a significant impact of AF on outcomes in patients undergoing TAVR including mortality, thrombo-embolic and bleeding events
The “Big Five” Complications After Transcatheter Aortic Valve . . .
However, as there are 2 sides to every coin, we must differentiate the periprocedural (probably embolic) stroke risk during the first 48 h, which accounts for only one-half of the TAVR-related strokes, from the later risk that may be associated with occult atrial fibrillation or subclinical valve thrombosis Fortunately, the TAVR-related stroke
Atrial Fibrillation After Heart Surgery: Important Facts
Eileen’s question was, “Is atrial fibrillation after heart valve surgery common?” As you may know… Atrial fibrillation is closely associated with heart valve disease For that reason, I wanted to get Eileen an expert opinion So, I tracked down Dr Marc Gillinov who is the new Chair of Cardiac Surgery at the Cleveland Clinic So you
Patients with New-Onset AFib after TAVR at Highest Risk for . . .
Researchers analyzed 13,356 patients undergoing TAVR at 381 sites across the U S From this group, 1,138 patients developed AFib for the first time after the procedure The study focused on how often new AFib was occurring, how it was managed if it did happen, and what the outcomes were for patients who developed AFib after TAVR
Atrial Fibrillation Management During Surgical vs . . .
Societal guidelines support concomitant treatment of atrial fibrillation (AF) in patients undergoing cardiac surgery 1 With the expansion of transcatheter aortic valve replacement (TAVR) to intermediate- and low-risk patients, many individuals with AF who would have previously received surgical aortic valve replacement (SAVR) with concomitant AF treatment are now being treated with TAVR alone
2020 ACC AHA Guideline for the Management of Patients With . . .
For patients with valvular heart disease and atrial fibrillation (except for patients with rheumatic mitral stenosis or a mechanical prosthesis), the decision to use oral anticoagulation to prevent thromboembolic events, with either a vitamin K antagonist or a non–vitamin K antagonist anticoagulant, should be made in a shared decision-making process based on the CHA 2 DS 2-VASc score
New-Onset Atrial Fibrillation After Transcatheter Aortic . . .
Risk Factors and Outcomes Associated With New-Onset AF After TAVR New-onset atrial fibrillation (AF) is a common complication of TAVR and is associated with increased mortality, longer stays in hospital, stroke, major bleeding, and the need for permanent pacemaker (PPM) implantation RR = risk ratio; TAVR = transcatheter aortic valve replacement
Trends and effect of atrial fibrillation on inpatient . . .
Atrial fibrillation (AF) is common in patients undergoing transcatheter aortic valve replacement (TAVR) but there is conflicting evidence on whether AF impacts outcomes after TAVR Methods Hospitalizations of adults ≥50 years old who had undergone elective TAVR from 2012 to 2015 were included
Postoperative Atrial Fibrillation Flutter After TAVR or SAVR
Postoperative atrial fibrillation or flutter (POAF) occurs in 12 3% of patients who undergo surgical or transcatheter valve replacement for severe aortic stenosis, with significantly higher incidence in the surgical group, both early and late Patients who experience late POAF or any POAF after